Cited by 598Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementAcute Ischemic Stroke Management

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.

National Trends in Ambulatory Oral Anticoagulant Use

Open access

Barnes, Geoffrey D., Lucas, Eleanor, Alexander, G. Caleb, Goldberger, Zachary D.·2015·The American Journal of Medicine

DOI 10.1016/j.amjmed.2015.05.044PMC PMC4658248

Open this paper in CoChat — free account Open PDF

Abstract

Background Four direct oral anticoagulants (DOACs) have been brought to market for the treatment of nonvalvular atrial fibrillation and venous thromboembolism. Many forces, including numerous positive trial results, emerging safety concerns, marketing, and promotion, may shape DOAC adoption by providers. However, relatively little is known regarding their ambulatory utilization compared with warfarin, as well as the degree to which they have decreased under-treatment of atrial fibrillation.Methods We used the IMS Health National Disease and Therapeutic Index, a nationally representative audit of outpatient office visits, to estimate the use of warfarin and DOACs between 2009 and 2014.Results Overall, visits with anticoagulation use increased from 2.05 (95% confidence interval [CI], 1.82-2.27) to 2.83 (95% CI, 2.49-3.17) million (M) quarterly visits (P < .001). Of these, DOAC use has grown to 4.21M (95% CI, 3.63M-4.79M; 38.2% of total) treatment visits in 2014 since their introduction in 2010. Use of all oral anticoagulants in treatment visits for atrial fibrillation has increased from 0.88M (95% CI, 0.74M-1.02M) to 1.72M (95% CI, 1.47M-1.97M; P < .001), with similar DOAC and warfarin use in 2014. Atrial fibrillation visits with anticoagulant use increased from 51.9% (95% CI, 50.4%-53.8%) to 66.9% (95% CI, 65.0%-69.3%) between 2009 and 2014 (P < .001). In 2014, rivaroxaban was the most commonly prescribed DOAC for atrial fibrillation (47.9% of office visits), followed by apixaban (26.5%) and dabigatran (25.5%).Conclusions Direct oral anticoagulants have been adopted rapidly, matching the use of warfarin, and are associated with increased use of oral anticoagulation for patients with atrial fibrillation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2015.05.044

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION
Tarver, T. (2014) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,595
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Cryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.025 · Cited by 929

Show all 41 references

Sorted by citations

Items 301–400 of 597

The Impact of Implementing an Advance Practice Pharmacist-Led Anticoagulation Clinic Within a Correctional Facility
Tran, N. T., Lin, C. H., Nguyen, N. D., Muradian, I. K., Lu, Q. D., & Henderson, S. O. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019892120 · Cited by 8
Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort
Swanson, K. M., Zhu, Y., Rojas, R. L., Sauver, J. L. S., Bielinski, S. J., Jacobsen, D. J., Visscher, S. L., Wang, L., Weinshilboum, R. M., & Borah, B. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233316 · Cited by 8
Prevalence and Outcome of Potential Candidates for Left Atrial Appendage Closure After Stroke With Atrial Fibrillation
Ong, E., Meseguer, E., Guidoux, C., Lavallée, P. C., Hobeanu, C., Charles, H., Labreuche, J., Cabrejo, L., Martin-Bechet, A., Rigual, R., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.029267 · Cited by 8
Geographic Variation in Anticoagulant Use and Resident, Nursing Home, and County Characteristics Associated With Treatment Among US Nursing Home Residents
Alcusky, M. J., Baek, J., Tjia, J., McManus, D. D., & Lapane, K. L. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.10.001 · Cited by 8
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
Alalawneh, M., Awaisu, A., & Rachid, O. (2022) · Clinical Pharmacokinetics · doi:10.1007/s40262-022-01160-z · Cited by 8
Extended anticoagulation for unprovoked venous thromboembolism
Castellucci, L. A., de Wit, K., Garcia, D. A., Ortel, T. L., & Gal, G. L. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12121 · Cited by 7
Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population
Tavares, L. C., Duarte, N. E., Marcatto, L. R., Soares, R. A. G., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2528-z · Cited by 8
Postoperative Anticoagulation After Neurologic Surgery
Passer, J. Z., & Loftus, C. M. (2018) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2018.06.008 · Cited by 8
A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines
Zerah, L., Bun, R. S., Guillo, S., Collet, J., Bonnet‐Zamponi, D., & Tubach, F. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211695 · Cited by 8
Utility of INR For Prediction of Delayed Intracranial Hemorrhage Among Warfarin Users with Head Injury
Valiuddin, H., Alam, A., Calice, M., Boehm, K. M., Millard, J., Laforest, D., Valiuddin, Y., Ricardi, R., Kaakaji, R., Koch, S. R., et al. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.01.003 · Cited by 8
Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery
Shukla, A. G., & Ramulu, P. Y. (2020) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001594 · Cited by 8
Emergency cardiac surgery in patients on oral anticoagulants and antiplatelet medications.
Akhrass, R., Gillinov, M., Bakaeen, F., Akras, D., Cameron, S., Bishop, J., Kapadia, S., & Svensson, L. (2021) · Journal of cardiac surgery · doi:10.1111/jocs.16027 · Cited by 5
Warfarin Therapy and Pharmacogenetics
Alridha, A. M. A., AL-GBURI, K. M. H., & Abbood, S. K. (2022) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_70_22 · Cited by 7
Rising Events and Improved Outcomes of Gastrointestinal Bleed With Shock in USA
Siddiqui, N. S., Paul, S., Khan, Z. H., Javaid, T., Hasan, S. S., Khan, Z., Saleh, J., Federman, D. J., Khuder, S., & Nawras, A. T. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000995 · Cited by 7
Management of epistaxis in patients with ventricular assist device: A retrospective review
Brown, C. S., Abi-Hachem, R. N., & Jang, D. W. (2018) · Journal of Otolaryngology - Head and Neck Surgery · doi:10.1186/s40463-018-0295-6 · Cited by 7
In‐hospital outcomes of STEMI patients on warfarin undergoing primary PCI
Marbach, J. A., Almufleh, A. S., Bernick, J., Blondeau, M., Osborne, C. M., Russo, J. J., Hibbert, B. M., Froeschl, M. P. V., Labinaz, M. X., Glover, C. A., et al. (2018) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.27720 · Cited by 7
4-Factor Prothrombin Complex Concentrate Administration via Intraosseous Access for Urgent Reversal of Warfarin
Peyko, V., Shams, D., Urbanski, R., & Noga, J. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.03.005 · Cited by 7
Breast Tissue Biology Expands the Possibilities for Prevention of Age-Related Breast Cancers
Fresques, T., Zirbes, A., Shalabi, S., Samson, S., Preto, S., Stampfer, M. R., & LaBarge, M. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00174 · Cited by 7
A Case Report of Rivaroxaban-Induced Urticaria and Angioedema With Possible Cross-Reaction to Dabigatran
Patil, T., & Ikekwere, C. (2019) · Journal of Medical Cases · doi:10.14740/jmc3399 · Cited by 7
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population‐based study
Kezerle, L., Tsadok, M. A., Senderey, A. B., Hoshen, M., Leventer‐Roberts, M., Reges, O., Leibowitz, M., & Haim, M. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14452 · Cited by 7
Implementation of the Management of Anticoagulation in the Periprocedural Period App Into an Electronic Health Record: A Prospective Cohort Study
Spyropoulos, A. C., Giannis, D., Cohen, J. L., John, S., Myrka, A., Inlall, D., Qiu, M., Akgul, S., Hyman, R. J., & WANG, J. J. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620925910 · Cited by 7
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation
Kawabata, M., Goya, M., Maeda, S., Yagishita, A., Takahashi, Y., Sasano, T., & Hirao, K. (2020) · International Heart Journal · doi:10.1536/ihj.19-625 · Cited by 7
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
Li, W., Barakakis, P. A., Palaiodimos, L., Kalaitzoglou, D., Tzelves, L. I., Manolopoulos, A., Wang, Y.-C., Giannopoulos, S., FAILLACE, R. T., & Kokkinidis, D. G. (2021) · World Journal of Cardiology · doi:10.4330/wjc.v13.i4.82 · Cited by 7
Trauma Response for Elderly Anticoagulated Patients: An Initiative to Reduce Trauma Resource Utilization in the Emergency Department
Pelaez, C. A., Spilman, S. K., Fuchsen, E. A., Semmens, A., & Sidwell, R. A. (2021) · Journal of Trauma Nursing · doi:10.1097/jtn.0000000000000577 · Cited by 7
An emulated target trial analysis based on Medicare data suggested non-inferiority of Dabigatran versus Rivaroxaban
Mei, H., Wang, J., & Ma, S. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.07.001 · Cited by 7
Utilization of anti–factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department
Zepeski, A. E., Faine, B. A., Merrill, A. E., Sutamtewagul, G., & Bhagavathi, S. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab326 · Cited by 7
Mild Head Trauma (MHT) and Antiplatelet Therapy. Reply to Lorenzati et al. Comment on “Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications? Medicina 2021, 57, 357”
Savioli, G., Ceresa, I. F., Luzzi, S., Lucifero, A. G., Cambiè, G., Manzoni, F., Preda, L., Ricevuti, G., & Bressan, M. A. (2021) · Medicina · doi:10.3390/medicina57090889 · Cited by 7
Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant
Minhas, A., Jiang, Q., Gu, X., Haymart, B., Kline-Rogers, E. M., ALMANY, S. L., Kozłowski, J., Krol, G. D., Kaatz, S. S., Froehlich, J. B., et al. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1377-9 · Cited by 7
Self-citation
Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time
Dubé, C., Douketis, J. D., Moffat, K. A., Schulman, S., & Blais, N. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.09.051 · Cited by 7
Perioperative Management of Direct Oral Anticoagulants in Intracranial Surgery
Porter, J. L., & Dinsmore, J. (2019) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000629 · Cited by 7
Medication Reconciliation and Patient Safety in Trauma: Applicability of Existing Strategies
DeAntonio, J. H., Leichtle, S. W., Hobgood, S. E., Boomer, L. A., Aboutanos, M. B., Mangino, M. J., Wijesinghe, D. S., & Jayaraman, S. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.09.041 · Cited by 7
Health-related quality of life in patients receiving oral anti-coagulants: a cross-sectional study
Sridharan, K., Banny, R. A., Qader, A. M., Husain, A., & Qader, K. M. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1760092 · Cited by 7
Web search popularity, publicity, and utilization of direct oral anticoagulants in the United States, 2008–2018
Ziakas, P. D., & Mylonakis, E. E. (2020) · Medicine · doi:10.1097/md.0000000000020005 · Cited by 7
Isolated Intracranial Hemorrhage in Elderly Patients With Pre-Injury Anticoagulation: Is Full Trauma Team Activation Necessary?
Diaz, J., Rooney, A. S., Calvo, R. Y., Benham, D. A., Carr, M. J., Badiee, J., Sise, C. B., Sise, M. J., Bansal, V., & Martin, M. J. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.07.021 · Cited by 7
Eastern Association for the Surgery of Trauma Multicenter Trial: Comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients.
Yorkgitis, B. K., Tatum, D. M., Taghavi, S., Schroeppel, T. J., Noorbakhsh, M. R., Philp, F. H., Bugaev, N., Mukherjee, K., Bellora, M., Ong, A. W., et al. (2022) · PubMed · doi:10.1097/ta.0000000000003421 · Cited by 6
An Eco-Friendly Ultra-Performance Liquid Chromatography–Mass Spectrometry Method for Quantification of Rivaroxaban and Ticagrelor in Rat Plasma: Grapefruit Interactions
Moffid, M. A., Mostafa, E. A., Mahmoud, S. T., & Sayed, R. M. (2023) · Bioanalysis · doi:10.4155/bio-2023-0138 · Cited by 6
Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most
Concha, M., Xu, L., Horn, M., Ohara, T., Nakamya, J., Beyer‐Westendorf, J., Shoamanesh, A., Cohen, A. T., Ladenvall, P., Connolly, S. J., et al. (2023) · Stroke Vascular and Interventional Neurology · doi:10.1161/svin.123.000997 · Cited by 6
Uptake and Utilization of the Management of Anticoagulation in the Periprocedural Period App: Longitudinal Analysis
Spyropoulos, A. C., Myrka, A., Triller, D. M., Ragan, S., York, C., King, J.-M., & Lee, T.-K. (2018) · JMIR mhealth and uhealth · doi:10.2196/11090 · Cited by 6
Heparin bridge is associated with more post-polypectomy bleeding and emergency department visits among anticoagulated patients
Rebello, D. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0430 · Cited by 6
Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups
Dietz, N., Ruff, C. T., Giugliano, R. P., Mercuri, M. F., & Antman, E. M. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.055 · Cited by 6
Use of non‐vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare database
Machado‐Alba, J. E., Gaviria‐Mendoza, A., Machado‐Duque, M. E., Tovar-Yepes, C. F., Ruigómez, A., & Rodríguez, L. A. G. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5124 · Cited by 6
Repeat head computed tomography for anticoagulated patients with an initial negative scan is not cost-effective
Borst, J. M., Godat, L. N., Berndtson, A. E., Kobayashi, L. M., Doucet, J. J., & Costantini, T. W. (2021) · Surgery · doi:10.1016/j.surg.2021.02.024 · Cited by 6
Association between transportation barriers and anticoagulation control among an inner‐city, low‐income population: A prospective observational cohort study
Yan, C. H., Naveed, M., Alobaidi, A., Kopfman, M., Nutescu, E. A., Sharp, L. K., & Cannegieter, S. C. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12605 · Cited by 6
Comparative hemostatic efficacy of 4F-PCC in patients with intracranial hemorrhage on factor Xa inhibitors versus warfarin
Heath, M., Hall, B., Leon, J. D., Gillespie, R., Hasara, S., Henricks, B., Lakshmi, M. R., Watson, D., & Wilson, K. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.04.044 · Cited by 6
Major Hemorrhage Risk Associated with Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis
Barakakis, P. A., Kokkinidis, D. G., Nagraj, S., Gidwani, V., Mavridis, T., & Ntaios, G. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2310334 · Cited by 6
Impact of educational intervention on management of periprocedural anticoagulation
Awker, A. L., Bell, M. A., McGraw, M., & Klein, M. A. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160726 · Cited by 6
A perspective on “The mythology of anticoagulation interruption for dental surgery”
Miller, C. S. (2018) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2017.11.005 · Cited by 6
Cost-Effectiveness of Bridging Anticoagulation Among Patients with Nonvalvular Atrial Fibrillation
Pappas, M. A., Barnes, G. D., & Vijan, S. S. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4796-9 · Cited by 6
Self-citation
Anticoagulation: a practical guide for strabismus surgeons
Robbins, S. L., Wang, J. W., Frazer, J. R., & Greenberg, M. (2019) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/j.jaapos.2018.12.008 · Cited by 6
Assessment of Oral Anticoagulant Adverse Drug Events Before and After Implementation of a Real-Time Clinical Surveillance Tool
Daniel, J., Kramer, J. S., & Burgess, L. H. (2019) · Journal of Patient Safety · doi:10.1097/pts.0000000000000607 · Cited by 6
Sulfonylureas and Metformin Were Not Associated With an Increased Rate of Serious Bleeding in Warfarin Users: A Self‐Controlled Case Series Study
Nam, Y. H., Han, X., Brensinger, C. M., Bilker, W. B., Leonard, C. E., & Hennessy, S. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1885 · Cited by 6
Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants
Fermann, G. J., Lovelace, B., Christoph, M. J., Lingohr-Smith, M., Lin, J., & Deitelzweig, S. B. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1837502 · Cited by 6
Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database
Guo, M., Thai, S., Zhou, J., Wei, J., Zhao, Y. J., Xu, W., Wang, T., & Cui, X. (2021) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01273-8 · Cited by 6
Comparing Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Extreme Obesity
Lorenz, M., & Linneman, T. W. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221116809 · Cited by 6
Long-Term Vitamin K Antagonists and Cancer Risk
Shurrab, M., Quinn, K. L., Kitchlu, A., Jackevicius, C. A., & Ko, D. T. (2019) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000571 · Cited by 6
Chronic Anticoagulation is Associated With Significantly Increased Rates of Medical Complications, Periprosthetic Joint Infection, and Revision After Primary Total Knee Arthroplasty
Goel, R. K., Ross, B. J., Heo, K. Y., Shah, J. A., Schwartz, A. M., Premkumar, A., & Wilson, J. M. (2025) · Arthroplasty Today · doi:10.1016/j.artd.2025.101749 · Cited by 5
Analysis of traumatic intracranial hemorrhage and delayed traumatic intracranial hemorrhage in patients with isolated head injury on anticoagulation and antiplatelet therapy
Raymond, K., Sterling, A., Roberts, M., Holland, R. W., Galwankar, S. C., Mishra, R., & Agrawal, A. (2023) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_270_2023 · Cited by 5
Before-After Study of an Electronic Order Set for Reversal of Vitamin K Antagonist–Associated Intracerebral Hemorrhage
Vitt, J. R., Do, L. V., Shah, N. H., Fong, G. R., Nguyen, N. Y., & Kim, A. (2017) · The Neurohospitalist · doi:10.1177/1941874417714706 · Cited by 5
Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation
Aronow, W. S., & Shamliyan, T. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000890 · Cited by 5
Is Continued Perioperative Antithrombotic Therapy Safe When Performing Direct Microlaryngoscopy?
Saba, E. S., Higgins, M. K., Heyes, R. R., & Lott, D. G. (2020) · The Laryngoscope · doi:10.1002/lary.28600 · Cited by 5
Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines
Gronemann, C., Hause, S., Assmann, A., Neumann, J. H. L., Schreiber, S., Heinze, H., & Goertler, M. (2020) · Cerebrovascular Diseases · doi:10.1159/000509416 · Cited by 5
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study
Rottenkolber, M., Schmiedl, S., Ibáñez, L., Sabaté, M., Ballarín, E., Vidal, X., León-Muñoz, L. M., Huerta, C., Martín‐Merino, E., Montero, D., et al. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13517 · Cited by 5
Findings on Repeat Posttraumatic Brain Computed Tomography Scans in Older Patients With Minimal Head Trauma and the Impact of Existing Antithrombotic Use
Flaherty, S. F., Biswas, S., Watts, D. D., Wilson, N. Y., Shen, Y., Garland, J. M., Wyse, R. J., Lieser, M. J., Duane, T. M., Offner, P. J., et al. (2022) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2022.08.006 · Cited by 5
Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report
Gumbis, G., Česnavičiūtė, I., Didžiokaitė, G., Gegeckienė, D., & Kvedarienė, V. (2023) · Journal of Asthma and Allergy · doi:10.2147/jaa.s413057 · Cited by 5
Connections between rodenticides and drugs: a review of natural compounds with ecological, biocidal and medical applications
Eason, C. (2017) · New Zealand Journal of Zoology · doi:10.1080/03014223.2017.1348956 · Cited by 5
Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy
Leonard, C. E., Brensinger, C. M., Bilker, W. B., Kimmel, S. E., Whitaker, H., & Hennessy, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-18318-6 · Cited by 5
Nation-Wide Use of Periprocedural Bridging Anticoagulation in Patients With Atrial Fibrillation
Barnes, G. D., Seiler, K., Brady, P., & Kamdar, N. S. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.08.020 · Cited by 5
Self-citation
Detecting direct oral anticoagulants in trauma patients using liquid chromatography–mass spectrometry: A novel approach to medication reconciliation
Jayaraman, S., DeAntonio, J. H., Leichtle, S. W., Han, J., Liebrecht, L. K., Contaifer, D., Young, C., Chou, C., Staschen, J., Doan, D., et al. (2019) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002527 · Cited by 5
Effect of SAMe-TT2R2 score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
Elewa, H. F., Qurishi, I., Abouelhassan, R., Safrah, S. A., Alhamoud, E., & Bader, L. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02102-x · Cited by 5
Impact of Pulmonary Embolism Response Team on Anticoagulation Prescribing Patterns in Patients With Acute Pulmonary Embolism
Kuhrau, S., Masic, D., Mancl, E. E., Brailovsky, Y., Porcaro, K., Morris, S., Haines, J. F., Charo, K., Fareed, J., & Darki, A. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020940125 · Cited by 5
Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban
Volod, O., Rollins‐Raval, M. A., Goodwin, A. J., IV, Higgins, R. A., Long, T. H., Chandler, W. L., Harris, N., Pham, H. P., Isom, J., Moser, K. A., et al. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0633-cp · Cited by 5
Incidence of Traumatic Delayed Intracranial Hemorrhage Among Patients Using Direct Oral Anticoagulants
Valiuddin, H., Calice, M., Alam, A., Millard, J., Boehm, K. M., Valiuddin, Y., Laforest, D., Ricardi, R., Kaakaji, R., & Keyes, D. C. (2021) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2021.04.017 · Cited by 5
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study
Baker, R. I., Gilmore, G., Chen, V. M. Y., Young, L., Merriman, E., Curnow, J. L., Joseph, J. E., Tiao, J. Y.-H., Chih, H., McRae, S. J., et al. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.100196 · Cited by 5
Oral Manifestations of Systemic Diseases and Their Treatments
Yeoh, S., Hua, H., Yepes, J. F., & Peterson, D. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-72303-7_18 · Cited by 6
Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosis
Ratté, M. T., Jones, A. E., Witt, D. M., & Young, D. C. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24512 · Cited by 5
Oral Manifestations of Systemic Diseases and their Treatments
Yeoh, S., Hua, H., Yepes, J. F., & Peterson, D. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-28100-1_18-1 · Cited by 5
The Pharmacoepigenomics Informatics Pipeline Defines a Pathway of Novel and Known Warfarin Pharmacogenomics Variants
Allyn-Feuer, A., Ade, A. S., Luzum, J. A., Higgins, G. A., & Athey, B. D. (2018) · Pharmacogenomics · doi:10.2217/pgs-2017-0186 · Cited by 5
Chemoprevention of Colorectal Cancer—With Emphasis on Low-Dose Aspirin and Anticoagulants
Agustsson, A. S., & Bjornsson, E. S. (2025) · Pharmaceuticals · doi:10.3390/ph18060811 · Cited by 5
Treatment of cerebral aneurysms with flow diversion or stent assisted coiling in patients on concurrent oral anticoagulation
Krishnakumar, H. N., Mascitelli, J. R., Hassan, A. E., Leary, J., & Son, C. (2022) · The Neuroradiology Journal · doi:10.1177/19714009221114443 · Cited by 4
Expedited surgery does not increase transfusion rates for patients with geriatric hip fracture taking factor Xa inhibitors
Wang, J., Nilssen, P. K., Stone, J., Breda, K., Little, M. T. M., Moon, C. N., & Lin, C. A. (2024) · OTA International The Open Access Journal of Orthopaedic Trauma · doi:10.1097/oi9.0000000000000292 · Cited by 4
Trends in physiological coagulation factors in Japanese patients receiving novel oral anticoagulants
Nagao, T., Hunakubo, H., Suzuki, M., Kataoka, T., Okumura, S., Shinoda, N., Harada, K., Kato, B., Kato, M., Marui, N., et al. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.07.011 · Cited by 4
Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat
Fairman, K. A., Davis, L. E., Kruse, C. R., & Sclar, D. A. (2016) · Applied Health Economics and Health Policy · doi:10.1007/s40258-016-0295-5 · Cited by 4
Treatment of gastrointestinal bleeding with idarucizumab in a patient receiving dabigatran
Mourafetis, J., Doctor, N., & Leung, S. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160980 · Cited by 4
Resuming Anticoagulation following Upper Gastrointestinal Bleeding among Patients with Nonvalvular Atrial Fibrillation�A Microsimulation Analysis
Pappas, M. A. (2019) · Journal of Hospital Medicine · doi:10.12788/jhm.3189 · Cited by 4
Physician Practice Patterns for Performing Thoracentesis in Patients Taking Anticoagulant Medications
DeBiasi, E. M., Murphy, T. E., Araujo, K. L. B., Pisani, M. A., & Puchalski, J. T. (2019) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000614 · Cited by 4
Reversal of Anticoagulants in Critical Care
Peter, J. V., & Subramani, K. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23257 · Cited by 4
Relation of apixaban bleeding rates to dose in patients with chronic kidney disease
Yun, S., Sevinsky, R., Spracklin, T., Tatara, A. W., & Fenves, A. Z. (2021) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2021.1930967 · Cited by 4
Safety of catheter ablation for atrial fibrillation in patients with mechanical prosthetic valves
Rozen, G., Elbaz‐Greener, G., Andria, N., Heist, E. K., Ruskin, J. N., Roguin, A., Carasso, S., Birati, E. Y., Amir, O., & Marai, I. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15459 · Cited by 4
Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center
Arshad, S., Davis, G. A., Amir, M., Goldberg, Y. H., Gupta, V. A., Abdel‐Latif, A., & Smyth, S. S. (2022) · Cardiology Research · doi:10.14740/cr1352 · Cited by 4
Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding
Sheikh‐Taha, M., Clark, H. L., & Crawley, R. M. (2023) · Clinical Drug Investigation · doi:10.1007/s40261-023-01316-0 · Cited by 4
Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies
Ferreira, L. O., Oldemburg, R. A. L., Filho, J. M. L., Cerveira, R. A., Vasconcelos, V. W., da Costa, G. E., Rodrigues, R. D. R., & Lopes, D. C. F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113077 · Cited by 4
Proton-pump inhibitors for the prevention of upper gastrointestinal bleeding in adults receiving antithrombotic therapy
Causada-Calo, N. S., Germini, F., Yuan, Y., Eikelboom, J. W., & Moayyedi, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013415 · Cited by 4
Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding
Thalji, N. K., & Camire, R. M. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000369 · Cited by 4
Equivalent inpatient mortality among direct-acting oral anticoagulant and warfarin users presenting with major hemorrhage
Bialkowski, W., Tan, S., Mast, A. E., Kiss, J. E., Kor, D. J., Gottschall, J. L., Wu, Y., Roubinian, N. H., Triulzi, D. J., Kleinman, S. H., et al. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.11.024 · Cited by 4
Spontaneous iliacus haematoma with femoral nerve palsy: an appeal to involve surgical teams early
Crawford, A. M., Guild, T. T., Striano, B. M., & Keudell, A. G. V. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-239024 · Cited by 4
High neutrophils and low lymphocytes percentages in bronchoalveolar lavage fluid are prognostic factors of higher in-hospital mortality in diffuse alveolar hemorrhage
Kanaoka, K., Minami, S., Ihara, S., & Komuta, K. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01660-x · Cited by 4
Head injury while on anticoagulation
Nearing, K. I., & Tsao, J. W. (2017) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000385 · Cited by 4
Gastrointestinal bleed mortality disparities in patients with atrial fibrillation: A cross‐sectional analysis 1999–2020
Sainbayar, E., Ibrahim, R., Noh, S., Pham, H. N., Shahid, M., Elias, J., Grewal, H., Mouhaffel, R., Folk, A., Hartnett, J., et al. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.13223 · Cited by 3
Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers
Cravo, E., Hays, H. L., Badeti, J., Spiller, H. A., Rine, N. I., Zhu, M., & Smith, G. A. (2025) · American Journal of Hematology · doi:10.1002/ajh.27595 · Cited by 3
Expedited Hip Fracture Surgery in Patients on Direct Oral Anticoagulants Does Not Increase Perioperative Blood Loss
Wang, J., Giammanco, P. A., Nilssen, P. K., Stone, J., Breda, K., Little, M. T. M., Moon, C. N., Yim, P. D., & Lin, C. A. (2025) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002974 · Cited by 3

Authors: Barnes, G. D., Lucas, E., Alexander, G. C., & Goldberger, Z. D.
Affiliations: University of Michigan (US)
Johns Hopkins University (US)
University of Washington (US)
Corresponding author: Barnes, Geoffrey D.
ORCID: Barnes, Geoffrey D.
Lucas, Eleanor
Alexander, G. Caleb
Goldberger, Zachary D.
Venue: The American Journal of Medicine
Publisher: Elsevier BV
Published: 2015-12
Volume: 128
Issue: 12
Pages: 1300-1305.e2
ISSN: 0002-9343 (ISSN-L)
DOI: 10.1016/j.amjmed.2015.05.044
PMC: PMC4658248
OpenAlex: W826970266
Cited by: 598
References: 41
Citations by year: 2026: 11 · 2025: 25 · 2024: 23 · 2023: 38 · 2022: 72 · 2021: 69 · 2020: 87 · 2019: 97 · 2018: 83 · 2017: 61 · 2016: 29 · 2015: 1
FWCI: 42.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The American Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01 HL107345, T32 HL007853-16)
Portola Pharmaceuticals
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: direct oral anticoagulants, warfarin, atrial fibrillation, venous thromboembolism, outpatient care, rivaroxaban, apixaban, dabigatran, prescribing patterns, drug adoption
MeSH terms: Rivaroxaban, Dabigatran, Administration, Oral, Adult, Age Factors, Aged, Ambulatory Care, Anticoagulants, Atrial Fibrillation, Female, Humans, Male, Middle Aged, Practice Patterns, Physicians', Pyrazoles, Pyridones, United States, Warfarin, Venous Thromboembolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

National Trends in Ambulatory Oral Anticoagulant Use

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks